Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →
Days to sell half: 0.1 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →
Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.
Sector mix
Share of the equity shown · NSE industry
Funds most like this one
Overlap of disclosed equity · the smaller share of each company both hold, added up
- ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETFAditya Birla Sun Life · 18 shared91.8%
- DSP Nifty Healthcare Index FundDSP · 18 shared91.8%
- Axis NIFTY Healthcare ETFAxis · 18 shared91.8%
- ICICI Prudential Nifty Healthcare ETFICICI Prudential · 18 shared91.8%
- DSP Nifty Healthcare ETFDSP · 18 shared91.8%
- Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 25 shared83.7%
- ICICI Prudential Nifty Pharma Index FundICICI Prudential · 17 shared77.4%
- Nippon India Nifty Pharma ETFNippon India · 17 shared77.4%
Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.
What changed in Sep 2026
This portfolio’s consecutive disclosures · evidenced adjustments applied
New positions
Complete exits
- None this month.
Largest increases
Largest reductions
- 01 Biocon Limited-4.1% -3,238
- 02 Aurobindo Pharma Limited-1.1% -346
- 03 Zydus Lifesciences Limited-1.0% -231
- 04 Sun Pharmaceutical Industries Limited-0.2% -198
- 05 Max Healthcare Institute Limited-0.2% -151
- 06 Dr. Reddy's Laboratories Limited-0.2% -109
- 07 Cipla Limited-0.2% -108
- 08 Fortis Healthcare Limited-0.2% -108
- 09 Laurus Labs Limited-0.1% -58
- 10 Aster DM Quality Care Limited-0.2% -51
Share quantities, not market values or cash flows.
Holdings by value
Sep 2026 · largest 100 · share of the equity shown
| Company | Sector | Size | Share of equity | Value | Shares held | Held since |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Healthcare | Large Cap | 15.23% | 20.04 Cr | 0.01 Cr | by Aug 2026 (2 mo+) |
| Divi's Laboratories Limited | Healthcare | Large Cap | 10.34% | 13.61 Cr | 14,648 | by Aug 2026 (2 mo+) |
| Apollo Hospitals Enterprise Limited | Healthcare | Large Cap | 7.66% | 10.08 Cr | 12,342 | by Aug 2026 (2 mo+) |
| Laurus Labs Limited | Healthcare | Mid Cap | 6.48% | 8.52 Cr | 43,046 | by Aug 2026 (2 mo+) |
| Torrent Pharmaceuticals Limited | Healthcare | Large Cap | 6.38% | 8.39 Cr | 17,489 | by Aug 2026 (2 mo+) |
| Cipla Limited | Healthcare | Large Cap | 6.33% | 8.33 Cr | 61,907 | by Aug 2026 (2 mo+) |
| Max Healthcare Institute Limited | Healthcare | Large Cap | 6.11% | 8.04 Cr | 86,518 | by Aug 2026 (2 mo+) |
| Dr. Reddy's Laboratories Limited | Healthcare | Large Cap | 5.75% | 7.57 Cr | 61,404 | by Aug 2026 (2 mo+) |
| Lupin Limited | Healthcare | Mid Cap | 4.32% | 5.69 Cr | 28,031 | by Aug 2026 (2 mo+) |
| Aurobindo Pharma Limited | Healthcare | Mid Cap | 4.03% | 5.31 Cr | 31,758 | by Aug 2026 (2 mo+) |
| Fortis Healthcare Limited | Healthcare | Mid Cap | 3.52% | 4.63 Cr | 60,170 | by Aug 2026 (2 mo+) |
| Glenmark Pharmaceuticals Limited | Healthcare | Mid Cap | 3.07% | 4.04 Cr | 17,301 | by Aug 2026 (2 mo+) |
| IPCA Laboratories Limited | Healthcare | Mid Cap | 2.50% | 3.30 Cr | 17,107 | by Aug 2026 (2 mo+) |
| Mankind Pharma Limited | Healthcare | Mid Cap | 2.41% | 3.17 Cr | 12,659 | by Aug 2026 (2 mo+) |
| Biocon Limited | Healthcare | Mid Cap | 2.15% | 2.83 Cr | 76,404 | by Aug 2026 (2 mo+) |
| Alkem Laboratories Limited | Healthcare | Mid Cap | 2.01% | 2.65 Cr | 5,132 | by Aug 2026 (2 mo+) |
| Gland Pharma Limited | Healthcare | Small Cap | 2.00% | 2.64 Cr | 9,098 | by Aug 2026 (2 mo+) |
| Zydus Lifesciences Limited | Healthcare | Mid Cap | 2.00% | 2.63 Cr | 22,635 | by Aug 2026 (2 mo+) |
| Aster DM Quality Care Limited | Healthcare | Small Cap | 1.51% | 1.99 Cr | 28,589 | by Aug 2026 (2 mo+) |
| Ajanta Pharma Limited | Healthcare | Small Cap | 1.47% | 1.94 Cr | 5,362 | by Aug 2026 (2 mo+) |
| Global Health Limited | Healthcare | Mid Cap | 1.03% | 1.35 Cr | 9,890 | by Aug 2026 (2 mo+) |
| Narayana Hrudayalaya Ltd. | Healthcare | Mid Cap | 1.02% | 1.34 Cr | 7,470 | by Aug 2026 (2 mo+) |
| GlaxoSmithKline Pharmaceuticals Limited | Healthcare | Mid Cap | 0.98% | 1.29 Cr | 4,674 | by Aug 2026 (2 mo+) |
| Wockhardt Limited | Healthcare | Small Cap | 0.90% | 1.18 Cr | 5,580 | Sep 2026 (1 mo) |
| Anthem Biosciences Limited | Healthcare | Mid Cap | 0.80% | 1.05 Cr | 12,201 | by Aug 2026 (2 mo+) |
Half of its current holdings have been held for 2 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.
Recent position changes
Latest 100 company-month records · evidenced adjustments applied
| Company | Month | Activity | Adjusted change |
|---|---|---|---|
| Wockhardt Limited | Sep 2026 | ▲ New position | +5,580 |
| Biocon Limited | Sep 2026 | ▼ Reducing | -3,238 |
| Anthem Biosciences Limited | Sep 2026 | ▲ Increasing | +1,506 |
| Aurobindo Pharma Limited | Sep 2026 | ▼ Reducing | -346 |
| Zydus Lifesciences Limited | Sep 2026 | ▼ Reducing | -231 |
| Sun Pharmaceutical Industries Limited | Sep 2026 | ▼ Reducing | -198 |
| Max Healthcare Institute Limited | Sep 2026 | ▼ Reducing | -151 |
| Dr. Reddy's Laboratories Limited | Sep 2026 | ▼ Reducing | -109 |
| Cipla Limited | Sep 2026 | ▼ Reducing | -108 |
| Fortis Healthcare Limited | Sep 2026 | ▼ Reducing | -108 |
| Laurus Labs Limited | Sep 2026 | ▼ Reducing | -58 |
| Aster DM Quality Care Limited | Sep 2026 | ▼ Reducing | -51 |
| Lupin Limited | Sep 2026 | ▼ Reducing | -48 |
| Glenmark Pharmaceuticals Limited | Sep 2026 | ▼ Reducing | -31 |
| Torrent Pharmaceuticals Limited | Sep 2026 | ▼ Reducing | -31 |
| IPCA Laboratories Limited | Sep 2026 | ▼ Reducing | -30 |
| Divi's Laboratories Limited | Sep 2026 | ▼ Reducing | -26 |
| Apollo Hospitals Enterprise Limited | Sep 2026 | ▼ Reducing | -21 |
| Mankind Pharma Limited | Sep 2026 | ▼ Reducing | -19 |
| Global Health Limited | Sep 2026 | ▼ Reducing | -15 |
| Narayana Hrudayalaya Ltd. | Sep 2026 | ▼ Reducing | -13 |
| Ajanta Pharma Limited | Sep 2026 | ▼ Reducing | -9 |
| Gland Pharma Limited | Sep 2026 | ▼ Reducing | -9 |
| GlaxoSmithKline Pharmaceuticals Limited | Sep 2026 | ▼ Reducing | -8 |
| Alkem Laboratories Limited | Sep 2026 | ▼ Reducing | -8 |
Changes compare consecutive month-end disclosures for this portfolio only.